Hedge Fund - Sarissa Capital Management
Ironwood Pharmaceuticals Inc (IRWD)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $72,607,700 | 22.48% | 16,390,000 | $4.06 |
| 2 | 2024 - Q3 (2024-09-30) | $67,526,800 | 16.78% | 16,390,000 | $5.38 |
| 3 | 2024 - Q2 (2024-06-30) | $106,862,800 | 18.03% | 16,390,000 | $7.07 |
| 4 | 2024 - Q1 (2024-03-31) | $142,756,900 | 24.97% | 16,390,000 | $12.13 |
| 5 | 2023 - Q4 (2023-12-31) | $187,501,600 | 28.89% | 16,390,000 | $9.89 |
| 6 | 2023 - Q3 (2023-09-30) | $157,835,700 | 21.26% | 16,390,000 | $9.80 |
| 7 | 2023 - Q2 (2023-06-30) | $174,389,600 | 17.36% | 16,390,000 | $10.75 |
| 8 | 2023 - Q1 (2023-03-31) | $172,422,800 | 22.05% | 16,390,000 | $11.20 |
| 9 | 2022 - Q4 (2022-12-31) | $203,072,100 | 24.16% | 16,390,000 | $11.34 |
| 10 | 2022 - Q3 (2022-09-30) | $169,800,000 | 19.19% | 16,390,000 | $11.34 |
| 11 | 2022 - Q2 (2022-06-30) | $188,977,000 | 19.02% | 16,390,000 | $11.78 |
| 12 | 2022 - Q1 (2022-03-31) | $206,186,000 | 19.48% | 16,390,000 | $11.46 |
| 13 | 2021 - Q4 (2021-12-31) | $191,107,000 | 16.54% | 16,390,000 | $12.27 |
| 14 | 2021 - Q3 (2021-09-30) | $214,053,000 | 16.8% | 16,390,000 | $12.92 |
| 15 | 2021 - Q2 (2021-06-30) | $210,939,000 | 16.77% | 16,390,000 | $11.45 |
| 16 | 2021 - Q1 (2021-03-31) | $183,240,000 | 17.56% | 16,390,000 | $10.56 |
| 17 | 2020 - Q4 (2020-12-31) | $159,915,000 | 16.32% | 14,040,000 | $10.94 |
| 18 | 2020 - Q3 (2020-09-30) | $126,289,000 | 14.86% | 14,040,000 | $9.94 |
| 19 | 2020 - Q2 (2020-06-30) | $144,892,000 | 16.11% | 14,040,000 | $10.23 |
| 20 | 2020 - Q1 (2020-03-31) | $136,467,000 | 17.41% | 13,525,000 | $11.75 |
| 21 | 2019 - Q4 (2019-12-31) | $137,186,000 | 11.38% | 10,307,000 | $11.03 |
| 22 | 2019 - Q3 (2019-09-30) | $86,734,000 | 10.87% | 10,103,000 | $9.72 |
| 23 | 2019 - Q2 (2019-06-30) | $106,314,000 | 13.25% | 9,718,000 | $11.24 |
| 24 | 2019 - Q1 (2019-03-31) | $102,045,000 | 15.36% | 9,005,386.8 | $13.33 |
| 25 | 2018 - Q4 (2018-12-31) | $64,773,000 | 14.35% | 7,465,246.2 | $13.70 |
| 26 | 2018 - Q3 (2018-09-30) | $62,156,000 | 13.71% | 4,020,317.4 | $18.87 |
| 27 | 2018 - Q2 (2018-06-30) | $64,378,000 | 12.9% | 4,020,317.4 | $17.67 |
| 28 | 2018 - Q1 (2018-03-31) | $51,954,000 | 12.02% | 4,020,317.4 | $14.88 |
| 29 | 2017 - Q4 (2017-12-31) | $24,733,000 | 6.33% | 1,970,100 | $15.60 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
597.0000:500.0000 on 2019-04-02